Sample Event QLD

PSA Administrator

20 March 2018

Details

Date:

April 28

Time:

07:00 pm - 10:00 pm

Event Category:

QLD

Click to Register: https://www.eventbrite.com/e/sample-event-qld-tickets-44353120377

Organizer

Website: https://www.eventbrite.com/o/bj-17079937463

Venue

Smart Store - Cash & Carry

Metro Manila, NCR 1235

Metro Manila, NCR, PH, 1235

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum

Evidence exists for only a small number of conditions

No evidence of benefit for several commonly treated conditions

Safety signals and quality concerns

Implications for Australians using medicinal cannabis

A national response

Inclusive endometriosis care

Normalisation is medical misogyny and delays diagnosis

Substantial financial costs

Pharmacists ‘underutilised’

‘Silent’ endometriosis

Using medicines better

Looking ahead

Bridging the gap in medicines access

Where access to CTG can fall short

Culturally safe care is more than good intentions

Every conversation is an opportunity

What regulators are seeing in practice

Rethinking how we approach CPD

Expanded scope increases responsibility

Embedding competence in everyday practice

Catching problems before they escalate

The hidden cost of delay

Complex patients, preventable harm

Prevention before crisis

Reform that matches need with value

Evidence exists for only a small number of conditions

No evidence of benefit for several commonly treated conditions

Safety signals and quality concerns

Implications for Australians using medicinal cannabis

A national response

Inclusive endometriosis care

Normalisation is medical misogyny and delays diagnosis

Substantial financial costs

Pharmacists ‘underutilised’

‘Silent’ endometriosis

Using medicines better

Looking ahead

Bridging the gap in medicines access

Where access to CTG can fall short

Culturally safe care is more than good intentions

Every conversation is an opportunity

What regulators are seeing in practice

Rethinking how we approach CPD

Expanded scope increases responsibility

Embedding competence in everyday practice

Catching problems before they escalate

The hidden cost of delay

Complex patients, preventable harm

Prevention before crisis

Reform that matches need with value

Evidence exists for only a small number of conditions

No evidence of benefit for several commonly treated conditions

Safety signals and quality concerns

Implications for Australians using medicinal cannabis

A national response

Inclusive endometriosis care

Normalisation is medical misogyny and delays diagnosis

Substantial financial costs

Pharmacists ‘underutilised’

‘Silent’ endometriosis

Using medicines better

Looking ahead

Bridging the gap in medicines access

Where access to CTG can fall short

Culturally safe care is more than good intentions

Every conversation is an opportunity

What regulators are seeing in practice

Rethinking how we approach CPD

Expanded scope increases responsibility

Embedding competence in everyday practice

Catching problems before they escalate

The hidden cost of delay

Complex patients, preventable harm

Prevention before crisis

Reform that matches need with value

Evidence exists for only a small number of conditions

No evidence of benefit for several commonly treated conditions

Safety signals and quality concerns

Implications for Australians using medicinal cannabis

A national response